Rafael Rodríguez | Public Health | Innovative Research Award

Innovative Research Award

                         Rafael Rodríguez
Affiliation Central Institute of Medicinal and Aromatic Plants
Country Spain
Scopus ID 58462293900
Documents 2
Citations 45
h-index 1
Subject Area Public Health
Event International Popular Scientist Awards

Rafael Rodríguez

Central Institute of Medicinal and Aromatic Plants

Rafael Rodríguez the Innovative Research Award recognizes scholarly achievement, research productivity, and contributions to scientific advancement. Rafael Rodríguez, affiliated with the Central Institute of Medicinal and Aromatic Plants, has developed a research profile associated with public health investigations and scholarly dissemination. Based on available bibliometric indicators, including indexed publications and citation performance, the researcher demonstrates participation in scientific activities relevant to evidence-based research and knowledge development.[1]

Abstract

This article presents an academic overview of Rafael Rodríguez and his suitability for recognition through the Innovative Research Award. The profile highlights scholarly activity, publication metrics, citation performance, and engagement with public health research. The assessment follows a neutral and evidence-based approach, emphasizing measurable indicators and documented academic outputs.[1]

Keywords

Innovative Research Award, Rafael Rodríguez, Public Health, Scientific Research, Citation Analysis, Academic Recognition, Research Impact, Scholarly Publications, Bibliometrics, International Popular Scientist Awards.

Introduction

Academic awards serve as mechanisms for recognizing excellence in research, innovation, and scholarly contribution. Within public health and related scientific disciplines, measurable indicators such as publication quality, citation influence, and participation in knowledge generation provide useful criteria for evaluating academic distinction. Rafael Rodríguez’s research record contributes to the broader landscape of scientific inquiry and demonstrates engagement with internationally indexed scholarly communication.[1]

Research Profile

Rafael Rodríguez is associated with the Central Institute of Medicinal and Aromatic Plants and maintains an indexed scholarly profile within the Scopus database. The available bibliometric record identifies a publication portfolio consisting of two indexed documents, supported by forty-five citations and an h-index value of one. These indicators reflect documented scholarly visibility and engagement within relevant research communities.[1]

Research Contributions

Research contributions associated with Rafael Rodríguez reflect participation in public health-related scientific investigations and dissemination through indexed scholarly publications. The documented work contributes to the ongoing development of evidence-based practices, scientific understanding, and academic dialogue within health-oriented research environments.[1]

Publications

The available bibliometric profile records two indexed scholarly documents. These publications form the foundation of the researcher’s documented academic contributions and serve as evidence of engagement in scientific research dissemination. Publication records indexed within major databases support visibility, discoverability, and citation tracking across international research communities.[1]

Research Impact

Research impact is commonly evaluated through citation metrics, publication visibility, and influence on subsequent scholarly work. The citation count associated with Rafael Rodríguez’s indexed publications indicates engagement by other researchers and demonstrates measurable academic reach. Citation-based indicators provide evidence that published findings have contributed to ongoing scientific discussions and referenced knowledge development.[1]

Although bibliometric indicators represent only one dimension of academic achievement, they remain valuable tools for assessing visibility and scholarly influence. The documented citation performance contributes positively to the evaluation of research significance within academic recognition programs.[1]

Award Suitability

The Innovative Research Award seeks to recognize researchers who demonstrate meaningful contributions to scientific advancement and scholarly communication. Rafael Rodríguez’s documented research activity, publication record, and citation performance align with several evaluation criteria commonly applied in academic award programs. The combination of indexed publications, measurable research influence, and engagement with public health topics supports consideration for recognition within the International Popular Scientist Awards framework.[1][2]

Conclusion

Rafael Rodríguez maintains a documented academic profile characterized by indexed publications, citation activity, and engagement in public health research. Based on available bibliometric information, the researcher demonstrates scholarly participation and measurable research visibility. These characteristics support the suitability of the researcher for consideration within academic recognition initiatives such as the Innovative Research Award and the International Popular Scientist Awards.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Rafael Rodríguez, Author ID 58462293900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58462293900
  2. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards Program Information.
    https://popularscientist.com/
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) System.
  4. Rodríguez, R., et al. (2026). The evolution of the Chemsex scene in Madrid, Spain.

Bruno Michel | Health Professions | Excellence in Research Award

Prof. Dr. Bruno Michel | Health Professions | Excellence in Research Award

Hôpitaux Universitaires de Strasbourg | France

Prof. Dr. Bruno Michel is an academic and researcher specializing in public health, clinical pharmacy, and pharmacoeconomics, with extensive professional experience in hospital and academic environments. His research focuses on optimizing medication use, improving patient safety, and enhancing healthcare efficiency through evidence-based approaches. He actively integrates big data and artificial intelligence into clinical decision-support systems to identify high-risk prescriptions and strengthen pharmaceutical interventions. With a strong record of scientific contributions, his publication metrics include an h-index of 14, over 818 citations, and 81 indexed documents, reflecting significant research impact. He contributes to interdisciplinary collaboration, academic mentoring, and innovation in healthcare systems.

Citation Metrics (Scopus)

1200

800

600

400

200

0

Citations
818

Documents
81

h-index
14

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Federica Tonon | Medicine | Research Excellence Distinction Award

Dr. Federica Tonon | Medicine | Research Excellence Distinction Award

Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) | Italy 

Dr. Federica Tonon is a biomedical researcher specializing in molecular biology, translational medicine, and clinical data science, with research focusing on cancer biology, hepatocellular carcinoma, endocrine pathways, and the renin–angiotensin system. Her work integrates advanced experimental models including zebrafish, murine systems, and stem cell technologies to investigate disease mechanisms, biomarkers, and therapeutic strategies. She has contributed to interdisciplinary projects combining laboratory research and clinical data management, supporting precision medicine approaches. Her scholarly impact includes 845 citations across 748 documents, with 38 Document and an h-index of 17, reflecting sustained contributions to biomedical research, innovation, and scientific advancement.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
845

Documents
38

h-index
17

🟦 Citations 🟥 Documents 🟩 h-index


View Scopus Profile
   View Orcid Profile

Featured Publications

Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Shandong Cancer Hospital China

Dr. Yuchun Wei is a leading Chinese physician-scientist in the field of oncology and nuclear medicine, currently working at the Shandong Cancer Hospital in Jinan, China. Born on November 22, 1987, she has contributed significantly to developing innovative imaging techniques for cancer diagnosis, staging, and individualized treatment planning. With deep expertise in PET/CT imaging biomarkers, she is committed to advancing precision oncology. 📡🧬

Profile

Scopus

Orcid

🎓 Education

Dr. Wei pursued her academic journey with a strong foundation in both Western and traditional Chinese medicine:

  • Ph.D. in Oncology from Shandong University (2018–2022), mentored by Academician Jinming Yu 🎓
  • Master’s in Oncology from Jinan University (2013–2016), under Prof. Shuanghu Yuan 🔬
  • Bachelor’s in Traditional Chinese and Western Clinical Medicine from Shandong University of Traditional Chinese Medicine (2007–2012) 🌿

💼 Professional Experience

Dr. Wei currently serves as a radiotherapy physician at Shandong Cancer Hospital (2017–present). She has also held several administrative and research leadership roles:

  • Deputy Director, MDT Quality Management Office (2021–2022)
  • Assistant Director, Radioimmunity and Molecular Imaging Room (2020–2021)
    Her clinical expertise is complemented by her operational leadership in multidisciplinary cancer care. 🏥⚕️

🔬 Research Interests

Her research revolves around novel imaging techniques, especially FAPI-based PET/CT imaging, with a focus on early detection, prognosis prediction, and therapy monitoring for cancers such as lung, esophageal, and cervical. Her goal is to refine personalized cancer treatment through quantitative imaging biomarkers. 🔍📊

🏆 Awards & Honors

Dr. Wei has been nominated for multiple research and innovation awards in recognition of her work in molecular imaging and radiation oncology. Her studies have earned significant visibility in top-tier journals (JCR Q1), and she is regarded as a rising star in clinical translational imaging. 🌟

📚 Publications Top Notes: 

Dr. Wei has authored and co-authored over 17 high-impact peer-reviewed papers, most of which appear in JCR Q1 journals. Here are her key publications with direct links and citation highlights:

FAPI Compared with FDG PET/CT for Lung Cancer Diagnosis
Radiology, 2023, IF: 19.7 | Cited by: 33

18F-FAPI PET/CT in Esophageal SCC Response Prediction
J Nucl Med, 2024, IF: 9.1 | Cited by: 12

Early Detection of Radiation-Induced Myocardial Damage
Eur J Nucl Med Mol Imaging, 2023, IF: 10.057 | Cited by: 40

18F-FAPI PET/CT Response in Chemoradiotherapy for ESCC
J Nucl Med, 2023, IF: 11.082 | Cited by: 25

Biodistribution and Targeting of 18F-FAPI-04
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 37

Differentiating Lung Cancer Types via PET/CT
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 31

Baseline Angiogenesis in NSCLC Prognosis
J Transl Med, 2022, IF: 8.44 | Cited by: 19

Differentiating Inflammatory Lung Lesions with FAPI
Eur Radiol, 2023, IF: 5.9 | Cited by: 10

Comparison Study in Mouse Model using PET Imaging
Sci Rep, 2016, IF: 5.228 | Cited by: 50

Radiation-Induced Lung Damage Model in Rats
Front Oncol, 2022, IF: 5.738 | Cited by: 14

Zainab El Arbi | Medicine and Health Sciences | Women Researcher Award

Mrs. Zainab El Arbi | Medicine and Health Sciences | Women Researcher Award

enseignante ISSEP-KS (Higher Institute of Sport and Physical Education of Ksar Saïd) Tunisia

Zaineb El Arbi is a dedicated Teacher and Researcher at the “Higher Institute of Sport and Physical Education of Ksar Said, Manouba University”, Tunisia, with a strong commitment to child motor development and adapted physical education. Beginning her career as a swimming coach and a teacher for deaf children, she has spent over a decade observing and addressing motor and behavioral challenges in young children. Her passion lies in shaping inclusive and intervention-based physical activity programs for preschoolers, especially those with special needs like deafness and autism.

Profile

Orcid

🎓 Education

Zaineb’s academic journey is rooted in the Sciences and Technics of Physical Activities and Sport, where she developed expertise in early childhood motor development and adaptive physical education. Her research is also deeply connected to her ongoing thesis, emphasizing practical, community-driven solutions for children’s physical well-being in Tunisia.

💼 Experience

Zaineb started her career as a swimming coach and an adapted physical education teacher at a special school for deaf children. Over the years, her hands-on work with children displaying motor and behavioral difficulties inspired her research into early intervention. Currently, she serves as a teacher and researcher at her institution, combining practical experience with scientific inquiry to support inclusive education in early childhood.

🔬 Research Interests

Zaineb’s primary research interests include motor development, motor impairments, and disabilities in preschoolers. Her work focuses on early detection and intervention strategies for Tunisian children, particularly those facing developmental challenges due to deafness or autism. She collaborates with specialized labs like Pearson Laboratory, using tools like the MABC-2 battery to assess motor competence in young children.

🏆 Awards

Zaineb is applying for the Prix de la femme chercheuse (Women Researcher Award) in recognition of her impactful work in child motor development. Her mission to improve early childhood education and public health through physical activity programs stands as a meaningful contribution to Tunisian society.

📚 Publications Top Notes: 

Zaineb recently published an article in the SpringerNature journal, Sport Sciences for Health, titled:
“Assessment of motor competence in Tunisian preschoolers using MABC-2 battery”
📖 Read Publication (2025)
📰 Journal: Sport Sciences for Health
🔗 Cited by: ResearchGate Article

George Simeakis | Medicine and Health Sciences | Best Researcher Award

Dr. George Simeakis | Medicine and Health Sciences | Best Researcher Award

Consultant Endocrinologist 401 General Military Hospital of Athens Greece

Dr. George Simeakis is a dedicated Greek endocrinologist with a remarkable career spanning over a decade. Currently serving as a Consultant Endocrinologist and Training Program Coordinator at the 401 General Military Hospital of Athens, he specializes in thyroid cancer and endocrine neoplasia. His contributions to thyroid cancer management and advanced endocrinology have made him a respected figure in his field.

Profile

Scopus

Orcid

Education 🎓

  • Ph.D. (Athens University School of Medicine, 2014–2024): Focused on the effects of glucocorticoids on bone metabolism in multiple sclerosis patients.
  • Subspecialty training in Thyroid Cancer (Alexandra Hospital, Athens, 2019–2021).
  • Visiting Fellow (Thyroid Oncology, Pisa, Italy, 2021).
  • Residency in Endocrinology (Alexandra Hospital, Athens).
  • Residency in Internal Medicine (401 General Military Hospital, Athens).

Experience 💼

  • Teacher, National and Kapodistrian University of Athens (Postgraduate Program in Endocrine Neoplasias, 2023–Present).
  • Consultant Endocrinologist, Thyroid Cancer Outpatient Clinic (2021–Present).
  • Training Program Coordinator, 401 General Military Hospital.
  • Private Practice Endocrinologist (Since 2013).
  • Sub-investigator and researcher in groundbreaking projects on thyroid cancer, circulating tumor markers, and more.

Research Interests 🔬

Dr. Simeakis’s research focuses on:

  • Thyroid cancer diagnostics and treatment, including radiofrequency ablation techniques.
  • Circulating tumor DNA (ctDNA) and cells (CTCs) in endocrine malignancies.
  • Bone health in autoimmune disorders like multiple sclerosis.

Awards & Honors 🏆

  • D. Ikkos Award (2024): Best publication in clinical endocrinology.
  • Chairmanship of Basic Cancer Symposium, 46th European Thyroid Association Meeting (2024).
  • Discussion Leader, Medullary Thyroid Cancer Poster Session (2024).

Publications Top Notes: 📚

“Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece”
Biomedicines, 2025. Read here
Cited by: 12 articles.

“Metastatic Medullary Thyroid Carcinoma: Disease Course, Treatment Modalities and Drug Resistance”
Endocrine, 2023. Read here
Cited by: 25 articles.

“High-Dose Intravenous Steroid Treatment in Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study”
Biomedicines, 2023. Read here
Cited by: 15 articles.

“Management of Endocrine Disease: Medullary Thyroid Cancer and Future Perspectives”
European Journal of Endocrinology, 2022. Read here
Cited by: 20 articles.